Analysis of prognostic factors in locally advanced and metastatic pancreatic cancer treated with gemcitabine or gemcitabine and S-1 chemotherapy using individual patient data from three randomized studies

被引：0
|
作者：
Nakai, Yousuke
Okusaka, Takuji
Ikari, Takaaki
Isayama, Hiroyuki
Furuse, Junji
Ishii, Hiroshi
Imai, Shogo
Okamura, Shota
Hamada, Chikuma
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[3] Tobu Chiiki Hosp, Tokyo, Japan
[4] Kyorin Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[5] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[6] Tokyo Univ Sci, Tokyo 162, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
223
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Gemcitabine plus S-1 treatment in locally advanced and metastatic pancreatic cancer: A pooled analysis of three randomized trials using updated individual patient data
    Okusaka, T.
    Ikari, T.
    Isayama, H.
    Furuse, J.
    Ishii, H.
    Nakai, Y.
    Imai, S.
    Okamura, S.
    Hamada, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S618 - S618
  • [2] Neoadjuvant Chemotherapy With Gemcitabine and S-1 for Locally Advanced Pancreatic Cancer
    Kin, T.
    Maguchi, H.
    Takahashi, K.
    Katanuma, A.
    Osanai, M.
    Yane, K.
    Ikarashi, S.
    Sen-yo, M.
    Minami, R.
    Sano, I.
    PANCREAS, 2014, 43 (08) : 1379 - 1379
  • [3] Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studies
    Yanagimoto, Hiroaki
    Ishii, Hiroshi
    Nakai, Yousuke
    Ozaka, Masato
    Ikari, Takaaki
    Koike, Kazuhiko
    Ueno, Hideki
    Ioka, Tatsuya
    Satoi, Sohei
    Sho, Masayuki
    Okusaka, Takuji
    Tanaka, Masao
    Shimokawa, Toshio
    Kwon, A-Hon
    Isayama, Hiroyuki
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (10) : 761 - 766
  • [4] Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia
    Li, Yanxun
    Sun, Jinjin
    Jiang, Zhijia
    Zhang, Linqiang
    Liu, Geng
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (04) : 227 - 234
  • [5] Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model
    Chang, Ching-Fu
    Huang, Pei-Wei
    Chen, Jen-Shi
    Chen, Yen-Yang
    Lu, Chang-Hsien
    Chang, Pei-Hung
    Hung, Yu-Shin
    Chou, Wen-Chi
    CANCERS, 2019, 11 (01)
  • [6] Combination Chemoherapy with S-1 and Gemcitabine for Locally Advanced and/or Metastatic Unresectable Pancreatic Cancer
    Takayama, Yukiko
    Shimizu, Kyoko
    Tahara, Junko
    Oyama, Hiroyasu
    Hayashi, Kazuhiko
    Shiratori, Keiko
    GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [7] Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors
    Sezgin, C
    Karabulut, B
    Uslu, R
    Sanli, UA
    Goksel, G
    Yuzer, Y
    Goker, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (12) : 1486 - 1492
  • [8] Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data
    Chikuma Hamada
    Takuji Okusaka
    Takaaki Ikari
    Hiroyuki Isayama
    Junji Furuse
    Hiroshi Ishii
    Yousuke Nakai
    Shogo Imai
    Shota Okamura
    British Journal of Cancer, 2017, 116 : 1544 - 1550
  • [9] A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Arizumi, Toshihiko
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Mizuno, Suguru
    Yamamoto, Keisuke
    Hirano, Kenji
    Tsujino, Takeshi
    Ijichi, Hideaki
    Toda, Nobuo
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    ONCOLOGY, 2009, 77 (05) : 300 - 303
  • [10] Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data
    Hamada, Chikuma
    Okusaka, Takuji
    Ikari, Takaaki
    Isayama, Hiroyuki
    Furuse, Junji
    Ishii, Hiroshi
    Nakai, Yousuke
    Imai, Shogo
    Okamura, Shota
    BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1544 - 1550
12345